First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: results of the TIMI 15A and 15B trials.
暂无分享,去创建一个
E. Braunwald | T. Henry | L. Jennings | B. Jensen | C. McCabe | R. Piana | R. Wise | R. Giugliano | M. Frey | J. Tamby | R. Sequeira | C. Mccabe | S. Nicolás